These effects, along with a preceding report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two aid the thought of focusing on ACKR3 as a unique solution to modulate the opioid procedure, which could open new therapeutic avenues for opioid-connected Issues.We independently exploration, critique, a